Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Newman Sund (NPI 1548215007)

Field	Value
Entity Type	Individual
Organization	Newman Sund
Address	6115 Falls Rd
City	Baltimore
State	MD
ZIP	21209
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 23, 2006

Payer Source	Total Paid
Medicare	$4M
Medicaid	$0

Key Findings

This is an ophthalmology practice with a clear retina/intravitreal focus: the top revenue drivers are injectable biologic codes and retina exams/imaging, led by J0178 ($2.7M, 3.9K claims, 67.2% of Medicare revenue), J2777 ($355K, 12.2K claims, 8.9%), and 92014 ($265.2K, 2.9K claims, 6.7%). The presence of high-volume injection and procedure codes such as 67028 (2.2K claims, $204.9K) plus retina imaging codes (92134, 92250) supports a service line built around frequent intravitreal therapy and diagnostic retinal care.

Revenue is highly concentrated: the precomputed top three Medicare codes account for 82.8% of this provider's total Medicare revenue, and total Medicare lifetime revenue is $4M. That concentration indicates financial reliance on a small set of high-value retina treatment codes rather than a broad mix of general ophthalmology E/M or primary care services.

The payer mix is effectively single-payer at the claims level: Medicare lifetime revenue is $4M and there is no Medicaid billing on file (none below). This provider should be treated as Medicare-dominant for network, utilization and payment benchmarking because Medicaid contributes no observable activity.

National competitive standing for the lead drug code is strong: J0178 ranks #75 of 3204 providers nationally (98th percentile) and is described as notably above typical national volume, indicating this provider is a major national user of aflibercept. Complementary procedure and imaging codes also show elevated standing (92014 ranks #70 of 35415, 100th percentile, described as an extreme outlier; 92250 ranks #158 of 25087, 99th percentile, extreme outlier), signaling above-average throughput across exam and diagnostic services.

Operational intensity is evident in injection throughput and procedure volumes: J0178 has 3.9K claims and 67028 has 2.2K claims, reflecting sustained procedure-level activity rather than sporadic use. At the same time, some injectable/drug codes show more typical volumes nationally (for example, J2777 ranks #866 of 2039, 57th percentile, described as typical and unremarkable), suggesting the practice focuses particularly on certain agents and services rather than uniformly high utilization across all retina drugs.

Smaller but meaningful revenue streams come from unclassified biologics and drug codes: J3590 accounts for $142K (56 claims, $2536 avg paid/claim, 3.6% of Medicare revenue) and J3490 accounts for $88.5K (51 claims, $1735 avg paid/claim, 2.2%). Both are ranked in the mid-to-lower national percentiles (J3590: #399 of 631, 37th percentile; J3490: #1590 of 2838, 43rd percentile) and represent ancillary sources of revenue rather than primary drivers.

The provider shows consistently high use of retinal diagnostic imaging and advanced office exam codes: 92134 reports 2K claims and $54.7K (96th percentile, notably above typical) and 92250 reports 1.2K claims and $33K (99th percentile, extreme outlier). These patterns indicate an established diagnostic workflow that supports frequent injection-based treatment decisions.

This NPI has long tenure in the dataset—enumerated 2006-05-23 (~20 years ago)—which, combined with concentrated Medicare revenue and extreme-percentile ranks on key ophthalmology codes, suggests an established, specialty-focused practice likely anchored by referral-driven intravitreal therapy and retina care pathways.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,890	$690	$2.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	12,240	$30	$355K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,910	$90	$265.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,180	$90	$204.9K
J3590	Unclassified biologics	60	$2,540	$142K
J3490	Unclassified drugs	50	$1,740	$88.5K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	560	$120	$66.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,950	$30	$54.7K
J2778	Injection, ranibizumab, 0.1 mg	190	$190	$36.3K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	1,180	$30	$33K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Newman Sund — 3 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	100	950	$690	$887.3K
J2777	25	70	8,520	$30	$487.3K
J2781	10	20	620	$120	$258.6K
J2778	47	50	650	$180	$207.8K
J3590	9	20	50	$2,390	$128.9K
67028	14	120	700	$100	$101.5K
J3490	65	100	70	$450	$62.1K
92014	12	620	210	$90	$44K
99214	9,279	10,270	150	$90	$24.1K
92235	72	90	70	$110	$19.5K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Newman Sund, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Virginia Oncology Associates	VA	Hematology & Oncology Physician	$0	$6.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Daniel Berinstein	MD	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Alexander Melamud	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Michael Lai	MD	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Jordana Fein	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Newman Sund, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Neel S. Satpute, Dds, PA	MD	Dental Clinic/Center	$0	$5M
Eric Suan	MD	Ophthalmology Physician	$3.8M	$0
Matthew Speicher	MD	Ophthalmology Physician	$3.7M	$0
Timothy Polk	MD	Ophthalmology Physician	$3.5M	$0
Chaim Mond	MD	Rheumatology Physician	$1.7M	$418.1K
Heather Tamez	MD	Retina Specialist (Ophthalmology) Physician	$1.3M	$0
Greenspring Surgery Center LLC	MD	Ambulatory Surgical Clinic/Center	$1M	$1.8K
Jeffrey Banker	MD	Cardiovascular Disease Physician	$683.4K	$0
Sunal Makadia	MD	Cardiovascular Disease Physician	$433.2K	$0
Lisa Grant	MD	Pain Medicine (Physical Medicine & Rehabilitation) Physician	$343.5K	$0

Newman Sund — Billing Profile & Reimbursement Data

Sign up for Newman Sund — Billing Profile & Reimbursement Data policy alerts

Newman Sund — Billing Profile & Reimbursement Data

Sign up for Newman Sund — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References